News

Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...
Anne Wojcicki’s nonprofit wins bid to acquire genetic testing company 23andMe
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Information Age6h
‘Thrilled’ 23andMe founder buys firm out of bankruptcy
The DNA data of more than 15 million customers of DNA testing firm 23andMe is set to be returned to the control of 23andMe co ...
Biotech company Regeneron to buy bankrupt 23andMe for $256M
Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...
NewsBytes2d
23andMe co-founder Anne Wojcicki has bought back the company
Anne Wojcicki's nonprofit is set to purchase all significant assets of the bankrupt genetic testing company, 23andMe, for ...
Anne Wojcicki to buy back 23andMe and its data for $305 million
Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.
ConsumerAffairs6d
States file suit to block the sale of 23andMe data
D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...
States Challenge 23andMe Over Genetic Data Sale in Bankruptcy Deal
States sue to halt Regeneron's 23andMe acquisition, citing privacy concerns over user DNA data, as a court-ordered report on ...
Anne Wojcicki is taking back control of 23andMe
Wojcicki, a co-founder and former CEO of 23andMe, is buying ‘substantially all’ of the company’s assets through a nonprofit.
STAT4dOpinion
I’m adopted. I still won’t use genetic testing services like 23andMe
A company like 23andMe can answer a lot of questions for an adoptee. But those answers come with a high cost to privacy.
Hosted on MSN23d
Does the 23andMe Acquisition Make Regeneron a Buy Now?
Is Regeneron a good stock to buy now in light of a potential 23andMe acquisition? Here's a quick look at what it's paying for to find out. What Regeneron could get for $256 million 23andMe's ...